Bio-Path Holdings, Inc.
P-ETHOXY NUCLEIC ACIDS FOR BCL2 INHIBITION

Abstract:

Provided herein are improved delivery systems for oligonucleotides, said delivery system comprising a liposome that comprises neutral phospholipids and a P-ethoxy oligonucleotide, which targets a BCL2-encoding polynucleotide. Methods of treating patients with said delivery systems are also provided.